To get around this, the semaglutide is combined with a special carrier molecule that acts like a bodyguard, protecting it just long enough to be absorbed into your bloodstream
Urva S, Coskun T, Loh MT et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicenter, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
10.3109/07420528.2012.658127 Chronobiol
Doses of semaglutide ranging from 0.1-1.6 mg resulted in a 2.1%, 7.0%, 13.0%, 37.5%, 51.2%, and 63.6% respective dose-dependent increases in the proportion of patients that achieved a 5%, or greater, reduction in weight loss
I knew the [00:18:00] injectables was a little bit of an uphill battle because it requires FD approval and all those things